RetinalGenix Technologies (RTGN) Retained Earnings (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Retained Earnings of -$18.4 million for Q1 2026, down 217.35% sequentially from $15.7 million in Q4 2025, and down 14.88% YoY from -$21.6 million in Q1 2025.
RetinalGenix Technologies (RTGN) Retained Earnings (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Retained Earnings for 7 years, with the latest figure at -$18.4 million in Q1 2026.
- Quarterly Retained Earnings fell 14.88% year-over-year to -$18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.4 million (down 14.88% YoY) and the FY2025 annual result came in at $15.7 million, up 201.61% from the prior year.
- Retained Earnings eased to -$18.4 million in Q1 2026 per RTGN's latest filing, from $15.7 million in the prior quarter.
- Over five years, Retained Earnings peaked at $15.7 million in Q4 2025 and troughed at -$18.4 million in Q1 2026.
- A 5-year average of -$5.8 million and a median of -$9.9 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings plunged 294.03% in 2022, then jumped 246.47% in 2023.
- Over 5 years, Retained Earnings stood at $7.9 million in 2022, then gained by 22.07% to $9.7 million in 2023, then tumbled by 259.04% to -$15.4 million in 2024, then surged by 201.61% to $15.7 million in 2025, then slumped by 217.35% to -$18.4 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$18.4 million, $15.7 million, and -$17.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.47 Bn | 193.87 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 119.67 Bn | 110.45 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 52.38 Bn | 48.13 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.76 Bn | 32.82 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 34.15 Bn | 32.04 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | - |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 3.15 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -18.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.40 Mn |
| Dec 31, 2025 | 15.68 Mn |
| Sep 30, 2025 | -17.24 Mn |
| Jun 30, 2025 | -16.70 Mn |
| Mar 31, 2025 | -16.02 Mn |
| Dec 31, 2024 | -15.43 Mn |
| Sep 30, 2024 | -14.56 Mn |
| Jun 30, 2024 | 12.11 Mn |
| Mar 31, 2024 | -13.26 Mn |
| Dec 31, 2023 | 9.70 Mn |
| Sep 30, 2023 | -10.57 Mn |
| Jun 30, 2023 | -9.88 Mn |
| Mar 31, 2023 | 8.03 Mn |
| Dec 31, 2022 | 7.95 Mn |
| Sep 30, 2022 | -8.30 Mn |
| Jun 30, 2022 | -5.80 Mn |
| Mar 31, 2022 | -5.48 Mn |
| Dec 31, 2021 | 4.64 Mn |
| Sep 30, 2021 | 4.28 Mn |
| Dec 31, 2020 | -2.93 Mn |